Preclinical evaluation of lovastatin.
暂无分享,去创建一个
S. Prahalada | D. Kornbrust | A. Alberts | R. J. Gerson | J. MacDonald | D. Bokelman | M. W. Kloss | P. H. Berry | J. Macdonald
[1] I. Chen,et al. The physiological disposition of lovastatin. , 1989, Drug metabolism and disposition: the biological fate of chemicals.
[2] J. Tobert. Efficacy and long-term adverse effect pattern of lovastatin. , 1988, The American journal of cardiology.
[3] A. Alberts,et al. Discovery, biochemistry and biology of lovastatin. , 1988, The American journal of cardiology.
[4] A. Alberts,et al. Brain and optic system pathology in hypocholesterolemic dogs treated with a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase. , 1988, The American journal of pathology.
[5] I. Singer,et al. Lovastatin, an inhibitor of cholesterol synthesis, induces hydroxymethylglutaryl-coenzyme A reductase directly on membranes of expanded smooth endoplasmic reticulum in rat hepatocytes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[6] D. Gordon,et al. 3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: a new class of cholesterol-lowering agents. , 1987, Annals of internal medicine.
[7] H. Brewer,et al. Testicular function in type II hyperlipoproteinemic patients treated with lovastatin (mevinolin) or neomycin. , 1987, Journal of Clinical Endocrinology and Metabolism.
[8] S. Fukushima,et al. Dose response in butylated hydroxyanisole induction of forestomach carcinogenesis in F344 rats. , 1986, Journal of the National Cancer Institute.
[9] A. Alberts,et al. Hydroxymethylglutaryl-coenzyme A reductase-containing hepatocytes are distributed periportally in normal and mevinolin-treated rat livers. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[10] F P Perera,et al. The genotoxic/epigenetic distinction: relevance to cancer policy. , 1984, Environmental research.
[11] R. Robertson,et al. Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase. , 1983, Teratology.
[12] G. Williams. Epignetic effects of liver tumor promoters and implications for health effects , 1983, Environmental health perspectives.
[13] I. J. Pachter,et al. An Analysis of the Carcinogenesis Testing Experience of the National Cancer Institute , 1982 .
[14] M. Brown,et al. Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. , 1980, Journal of lipid research.
[15] J. Jancar. ANTICONVULSANT DRUGS AND CANCER , 1980, The Lancet.
[16] Endo Akira,et al. Effects of ML-236B on cholesterol metabolism in mice and rats: Lack of hypocholesterolemic activity in normal animals , 1979 .
[17] M. Wiley,et al. Essential role for mevalonate synthesis in DNA replication. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[18] S. White,et al. ANTICONVULSANT DRUGS AND CANCER A Cohort Study in Patients with Severe Epilepsy , 1979, The Lancet.
[19] A. Adamany,et al. Impairment of dolichyl saccharide synthesis and dolichol-mediated glycoprotein assembly in the aortic smooth muscle cell in culture by inhibitors of cholesterol biosynthesis. , 1978, The Journal of biological chemistry.
[20] W. Bensch,et al. Lack of correlation between the rate of cholesterol biosynthesis and the activity of 3-hydroxy-3-methylgutaryl coenzyme A reductase in rats and in fibroblasts treated with ML-236B. , 1978, Biochemical and biophysical research communications.
[21] B. Ed,et al. Biochemistry of Polyisoprenoid Biosynthesis , 1976 .
[22] J. Nordstrom,et al. Regulation of HMG-CoA reductase. , 1976, Advances in lipid research.
[23] J. Simpson. Letter: Weather and myasthenic fatigue. , 1974, Lancet.
[24] E. Staffeldt,et al. Brief communication: Enhancement of spontaneous hepatic tumorigenesis in C3H mice by dietary phenobarbital. , 1973, Journal of the National Cancer Institute.
[25] Kirby Tj. Cataracts produced by triparanol. (MER-29). , 1967 .
[26] R. Olson. Biosynthesis of ubiquinones in animals. , 1966, Vitamins and hormones.